Delivery Order SPE2DB22D9239-SPE2DB25FDE73

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,578.80 and an ultimate completion date of March 24, 2025. The contract covers the delivery of Sodium Chloride Injection, a medical supply item, to support the government's medical supply needs. DMS Pharmaceutical Group has a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,927.65 order is for 4565804191 - Sodium Chloride 0.9% Solution 250ML. The order has a completion date of September 16, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025....
This federal contract award is for a Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,640.40, is for the delivery of Sodium Chloride 0.9% 50s to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), valued at $1,387.64, for the supply of sodium chloride injection. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 6, 2025 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is not set aside and allows DMS Pharmaceutical Group to provide a range of pharmaceutical products, including branded and generic...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,228.00 firm fixed-price delivery order is for the supply of sodium chloride injection. This award is associated with a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract provides for the delivery of 0.9% sodium chloride solution (500 ml) to support the medical supply needs of military health facilities. The $1,089.91 delivery order has a firm fixed-price pricing type and an ultimate completion date of February 24, 2025. DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,047.08 firm fixed-price delivery order covers the supply of sodium chloride 0.9% vial 10ml medical products to support the recurring medical supply needs of military health facilities worldwide. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,060.75, is for the delivery of 4562099020 - Sodium Thiosulfat 12.5 G/50 ML 50ML. This order falls under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,158.22 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4562098253 - SODIUM THIOSULFAT 12.5 G/50 ML 50ML, with a completion date of August 4, 2023. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,088.55 contract was awarded on June 6, 2025 by the Defense Logistics Agency (DLA) and has an ultimate completion date of June 9, 2025. The contract is for the delivery of 50 ml bottles of sodium thiosulfate. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDE73
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $3,772.32 and covers the delivery of 4566580863 - Sodium Chloride 400 MEQ/100 ML 100ML to the government. The contract has an ultimate completion date of November 22, 2024 and is not associated with any set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

Generated 2/20/25, 9:08 AM